Skip Navigation

skip navigationNIDDK Home
NIDDK Reference Collection
Diet   Exercise   Health  

Due to server maintenance, this site will be unavailable from 12 a.m. – 5 a.m. on November 21 and November 22, 2009.

Home Page
-  

FAQ

Detailed Search

- -
NIDDK INFORMATION SERVICES
- -

Diabetes

Digestive Diseases

Endocrine and Metabolic Diseases

Hematologic Diseases

Kidney and Urologic Diseases

Weight-control Information Network

-
NIDDK EDUCATION
PROGRAMS

- -

National Diabetes Education Program

National Kidney Disease Education Program

-
- - -
NIDDK Home
-
Contact Us
-
New Search
-

Link to this page

Your search term(s) "diabetes prevention program" returned 17 results.

Page 1 2    Display All


Diabetes Mellitus Interagency Coordinating Committee (DMICC): Coordinating the Federal Investment in Diabetes Programs to Improve the Health of Americans. Bethesda, MD: National Diabetes Information Clearinghouse.2009. 43 p.

This booklet describes in detail the Diabetes Mellitus Interagency Coordinating Committee (DMICC), a group that facilitates cooperation, communication, and collaboration on diabetes research and programs among the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH), other agencies of the Department of Health and Human Services, and other federal departments and agencies that conduct or support diabetes-related activities. The DMICC holds meetings several times a year to identify emerging issues and opportunities, and to develop ways in which different government components can work together and build on each other’s expertise and resources. The booklet lists DMICC member organizations and explains how the DMICC coordinates activities across the government. The bulk of the booklet describes some examples of diabetes activities that have been successfully coordinated across the government, with the help of the DMICC. Programs described include the National Diabetes Education Program (NDEP); the Diabetes Prevention Program (DPP) clinical trial; programs to improve the health of Hispanic and Latino communities, African American communities, American Indian communities, and to combat diabetes in children; programs to improve the delivery of health care to special populations; the U.S. Centers for Disease Control and Prevention’s Division of Diabetes Translation (CDC DDT); and collaborative research efforts including the Diabetes Prevention Program Outcomes Study (DPPOS), the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial, Look AHEAD: Action for Health in Diabetes, the Environmental Determinants of Diabetes in the Young (TEDDY) study, the Clinical Islet Transplantation Consortium (CIT), and the SEARCH for Diabetes in Youth study. One section briefly summarizes some of the future DMICC activities in the areas of membership development, strengthening collaboration, and enhancing outreach efforts. Readers are encouraged to visit the DMICC’s website at www2.niddk.nih.gov/AboutNIDDK/CommitteesAndWorkingGroups/DMICC. The booklet is illustrated with full-color photographs. A list of acronyms is provided. 9 references.

Full Record   Printer Friendly Version


 

Diabetes Overview. Bethesda, MD: National Diabetes Information Clearinghouse. 2008. 16 p.

This fact sheet provides an overview of information about diabetes, defined as a disorder of metabolism. The fact sheet describes the three main types of diabetes: type 1 diabetes, an autoimmune disease in which the pancreas produces little or no insulin; type 2 diabetes, in which the body does not produce enough insulin or uses insulin inefficiently; and gestational diabetes, which is associated with pregnancy and a subsequent increased risk for type 2 diabetes. The fact sheet discusses diagnostic considerations, the condition of pre-diabetes, the complications that may be associated with diabetes, epidemiology of type 1 and type 2 diabetes, and patient care for people with diabetes. The fact sheet describes current research efforts in the diabetes arena, including the Diabetes Prevention Trial–Type 1 (DPT-1), the Environmental Determinants of Diabetes in the Young Consortium (TEDDY), Type 1 Diabetes TrialNet, the Immune Tolerance Network, the Trial to Reduce IDDM in the Genetically at Risk (TRIGR), islet transplantation studies, the Diabetes Prevention Program (DPP), studies on type 2 diabetes in children and teens, and studies focusing on preventing and treating cardiovascular disease in people with type 2 diabetes. Contact information for three resource organizations is listed: the American Diabetes Association at www.diabetes.org or 1–800–342–2383, the National Diabetes Education Program at www.ndep.nih.gov or 1–888–693–6337, and the Juvenile Diabetes Research Foundation International at ww.jdrf.org or 1–800–533–2873. A final section provides contact information and a brief description of the goals and activities of the National Diabetes Information Clearinghouse (NDIC), a Government service that provides information about diabetes to people with diabetes and to their families, health care professionals, and the public. 1 figure.

Full Record   Printer Friendly Version


 

Providing Long-Term Support for Lifestyle Changes: A Key to Success in Diabetes Prevention. Diabetes Spectrum. 20(4): 205-209. Fall 2007.

This article is one from a series on the importance of diabetes self-management education (DSME) in the everyday care of people with diabetes and in prevention of the complications of the disease. The authors remind readers that there is increasing evidence to demonstrate that type 2 diabetes can be delayed or prevented in people with elevated risk by modest changes in lifestyle. The authors explore how partnering with the YMCA organization can result in a community-based intervention approach to implement diabetes prevention programs. YMCA staff trained to deliver a structured lifestyle intervention to prevent diabetes can achieve short-term weight-loss results comparable to those achieved during the Diabetes Prevention Program clinical trial. The authors comment on the importance of maintaining intervention programs to maintain the benefits they [s2]can achieve. 42 references.

Full Record   Printer Friendly Version


 

Diabetes Overview. Bethesda, MD: National Diabetes Information Clearinghouse. 2006. 16 p.

This fact sheet provides an overview of information about diabetes, defined as a disorder of metabolism. The fact sheet describes the three main types of diabetes: type 1 diabetes, an autoimmune disease in which the pancreas produces little or no insulin; type 2 diabetes, in which the body does not produce enough insulin or uses insulin inefficiently; and gestational diabetes, which is associated with pregnancy and an increased risk of type 2 diabetes subsequently. The fact sheet then discusses diagnostic considerations, the condition of pre-diabetes, the complications that may be associated with diabetes, epidemiology of type 1 and type 2 diabetes, and patient care for people with diabetes. The fact sheet also describes current research efforts in the diabetes arena, including the Environmental Determinants of Diabetes in the Young Consortium (TEDDY), Type 1 Diabetes TrialNet, the Immune Tolerance Network, islet transplantation studies, the Diabetes Prevention Program (DPP), studies on type 2 diabetes in children and teens, and studies focusing on preventing and treating cardiovascular disease in people with type 2 diabetes. The contact information for four resource organizations is listed. A final section provides the contact information and a brief description of the goals and activities of the National Diabetes Information Clearinghouse. 2 figures.

Full Record   Printer Friendly Version


 

Lifestyle for Prevention: Choices, Changes, Challenges. IN: Mensing, C., ed. Art and Science of Diabetes Self-Management Education. Chicago, IL: American Association of Diabetes Educators. pp. 22-42.

This chapter on lifestyle for the prevention of diabetes is from a comprehensive text that serves as a resource for all health professionals, community professionals, and individuals who provide education to individuals with diabetes. The authors note that the prevention and delay of diabetes and the chronic complications associated with diabetes have become urgently important in both public health and patient care. Education plays a large role in preventing and delaying the onset of type 2 diabetes, as well as in preventing and controlling its devastating complications. Topics covered include risk factors and their interactions, the effectiveness of lifestyle intervention in diabetes prevention, related landmark studies including the Diabetes Prevention Program (DPP), self-care behaviors, translating prevention research for diverse populations and settings, a clinical approach for high-risk individuals, the Medicare Medical Nutrition Therapy Act of 2005, and the role of a community approach to diabetes prevention. The chapter includes a list of key points, a summary of teaching strategies, suggested Internet resources, a glossary of key terms, and a list of references. 1 figure. 4 tables. 44 references.

Full Record   Printer Friendly Version


 

Your Game Plan to Prevent Type 2 Diabetes. Information for Patients. Bethesda, MD: National Diabetes Education Program. 2006. 20 p.

This booklet provides fat and calorie content information to help people following a "Game Plan" for diabetes prevention. The "Game Plan" is based on the Diabetes Prevention Program (DPP) research study that showed that type 2 diabetes could be prevented or delayed in people with increased risk by losing a small amount of weight and getting 30 minutes of moderate-intensity physical activity. This booklet lists foods alphabetically, with the serving size, number of fat grams, and calories noted for each item. The back cover has the contact information for the National Diabetes Education Program (NDEP).

Full Record   Printer Friendly Version


 

Your Game Plan to Prevent Type 2 Diabetes. Information for Patients. Bethesda, MD: National Diabetes Education Program. 2006. 20 p.

This booklet offers information about diabetes prevention for people at high risk for developing diabetes. The two main keys to success are getting at least 30 minutes of moderate-intensity physical activity five days a week, and eat a variety of foods that are low in fat and reduce the number of calories eaten each day. The booklet presents a "Game Plan" which is based on the Diabetes Prevention Program (DPP) research study that showed that type 2 diabetes could be prevented or delayed in people with increased risk by losing a small amount of weight and getting 30 minutes of moderate-intensity physical activity. This booklet is designed to help readers take steps to prevent diabetes, set goals, and track their progress. The chapters of the booklet cover the risk factors for type 2 diabetes and pre-diabetes, small steps for eating healthy foods, and small steps for getting more physical activity. The booklet also includes food and activity tracker pages for photocopying and a list of additional resources, with their telephone numbers and web site addresses. The booklet is illustrated with photographs of people living an active lifestyle. 2 figures. 5 tables.

Full Record   Printer Friendly Version


 

Clinical Outcomes and Cost-Effectiveness of Strategies for Managing People at High Risk for Diabetes. Annals of Internal Medicine. 143(4): 251-264, W53-W68. August 2005.

Lifestyle modification can forestall diabetes in high-risk people, but the long-term cost-effectiveness is uncertain. This article reports on a study undertaken to estimate the effects of the lifestyle modification program used in the Diabetes Prevention Program (DPP) on health and economic outcomes. The authors performed a cost-effectiveness analysis using the Archimedes model. Results showed that, compared with no prevention program, the DPP lifestyle program would reduce a high-risk person's 30-year chances of getting diabetes from about 72 percent to 61 percent, the chances of a serious complication from about 38 percent to 30 percent, and the chances of dying of a complication of diabetes from about 13.5 percent to 11.2 percent. The drug metformin would deliver about one-third of the long-term health benefits achievable by immediate lifestyle modification. Compared with not implementing any prevention program, the expected 30-year cost per quality-adjusted life-year (QALY) of the DPP lifestyle intervention from the health plan's perspective would be about $143,00. From a societal perspective, the cost per QALY of the lifestyle intervention (compared with doing nothing) would be about $62,600. Either using metformin of delaying the lifestyle intervention until after a person develops diabetes would be more cost-effective, costing about $35,400 or $24,500 per QALY gained, respectively, compared with no program. Compared with delaying the lifestyle program until after diabetes is diagnosed, the marginal cost-effectiveness of beginning the DPP lifestyle program immediately would be about $201,800. Compared with no program, lifestyle modification for high-risk people can be made cost-saving over 30 years if the annual cost of the intervention can be reduced to about $100. The authors conclude that lifestyle modification is likely to have important effects on the morbidity and mortality of diabetes and should be recommended to all high-risk people. However, the program used in the DPP study may be too expensive for health plans or a national program to implement. The authors call for less expensive methods to achieve the degree of weight loss seen in the DPP. A lengthy appendix is included that contains additional information about the Archimedes model pertinent to the analysis of the prevention and management of diabetes in high-risk people. 10 figures. 10 tables. 48 references.

Full Record   Printer Friendly Version


 

Fishes, Whales, and Fishing Tips: Hooking an Active Lifestyle. Diabetes Spectrum. 18(2): 114-118. Spring 2005.

Given that a physically active lifestyle is important to health and quality of life, health care professionals are faced with the challenge of guiding individuals as they attempt to increase their level of physical activity. This article shares the suggestions of several lifestyle interventionists (many of whom were part of the Diabetes Prevention Program) gleaned from their experiences with participants and patients whom they have encountered through the years. The authors first review the benefits of an active lifestyle for people with diabetes, then discuss the problem of many people who continue to choose a sedentary lifestyle. Other topics covered include public health recommendations, the Diabetes Prevention Program (DPP) and its findings, the importance of maintaining any exercise or activity program, the fun of exercising with friends, creative ways to incorporate exercise and activity into everyday life, and how to handle and overcome barriers to exercise. 13 references.

Full Record   Printer Friendly Version


 

Cost-Effectiveness of Lifestyle Modification or Metformin in Preventing Type 2 Diabetes in Adults with Impaired Glucose Tolerance. Annals of Internal Medicine. 142(5): 323-332. March 2005.

The Diabetes Prevention Program (DPP) demonstrated that interventions can delay or prevent the development of type 2 diabetes. This article reports on a study undertaken to estimate the lifetime cost-utility of the DPP interventions. The authors use a Markov simulation model to estimate progression of disease, costs, and quality of life. The interventions considered include intensive lifestyle, metformin, and placebo. The results showed that, compared with the placebo intervention, the lifestyle and metformin interventions were estimated to delay the development of type 2 diabetes by 11 years and 3 years, respectively, and to reduce the absolute incidence of diabetes by 20 percent and 8 percent, respectively. The cumulative incidence of complications were reduced and survival was improved by 0.5 years and 0.2 years. Compared with the placebo intervention, the cost per quality adjust life-years (QALY) was approximately $1100 for the lifestyle intervention and $31,300 for the metformin intervention. From a societal perspective, the interventions cost approximately $8,800 and $29,900 per QALY, respectively. From both perspectives, the lifestyle intervention outperformed the metformin intervention. The authors caution that simulation results depend on the accuracy of the underlying assumptions, including participant adherence.

Full Record   Printer Friendly Version


 

Page 1 2    Display All

Start a new search.


View NIDDK Publications | NIDDK Health Information | Contact Us

The NIDDK Reference Collection is a service of the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health.
NIDDK Clearinghouses Publications Catalog
5 Information Way
Bethesda, MD 20892–3568
Phone: 1–800–860–8747
TTY: 1–866–569–1162
Fax: 703–738–4929
Email: catalog@niddk.nih.gov

Privacy | Disclaimers | Accessibility | Public Use of Materials
H H S logo - link to U. S. Department of Health and Human Services NIH logo - link to the National Institute of Health NIDDK logo - link to the National Institute of Diabetes and Digestive and Kidney Diseases